| Female breast cancer | Prostate cancer | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Univariate | Adjusted; age & deprivation | Univariate | Adjusted; age & deprivation | ||||||||||
Risk difference (95Â % CI) | p-value | Risk difference (95Â % CI) | p-value | Risk difference (95Â % CI) | p-value | Risk difference (95Â % CI) | p-value | ||||||
Patient level | Age | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
65 + yrs | Baseline | Baseline | Baseline | Baseline | |||||||||
45-64 years | −3.2 | (−4.1 to −2.4) | <0.001 | −3.2 | (−4.1 to −2.4) | <0.001 | −8.1 | (−9.4 to −6.8) | <0.001 | −8.2 | (−9.4 to −6.9) | <0.001 | |
15-44 years | 2.1 | (0.6 to 3.6) | 0.01 | 1.9 | (0.4 to 3.4) | 0.01 | −19.0 | (−29.5 to −8.5) | <0.001 | −19.7 | (−30.2 to −9.3) | <0.001 | |
Ethnicity | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | |
White | Baseline | Â | Baseline | Â | |||||||||
Non-white | 6.0 | (3.3 to 8.6) | <0.001 |  |  |  | −6.0 | (−10.3 to −1.7) | 0.01 |  |  |  | |
Deprivation | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | |
Q1 (least deprived) | Baseline | Baseline | Baseline | Baseline | |||||||||
Q2 | −0.6 | (−1.8 to 0.6) |  | −0.8 | (−1.9 to 0.4) |  | 2.1 | (0.5 to 3.8) |  | 2.0 | (0.4 to 3.7) |  | |
Q3 | 0.0 | (−1.2 to 1.2) |  | −0.1 | (−1.3 to 1.0) |  | 2.7 | (1.0 to 4.5) |  | 2.6 | (0.9 to 4.3) |  | |
Q4 | 2.5 | (1.2 to 3.8) | Â | 2.2 | (1.0 to 3.5) | Â | 4.1 | (2.2 to 6.0) | Â | 4.2 | (2.3 to 6.0) | Â | |
Q5 (most deprived) | 3.9 | (2.5 to 5.3) | <0.001 | 3.6 | (2.2 to 5.0) | <0.001 | 4.7 | (2.7 to 6.8) | <0.001 | 4.9 | (2.9 to 7.0) | <0.001 | |
GP demographics | Number of patients per GP | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
Q1 (lowest) | Baseline | Baseline | Baseline | Baseline | |||||||||
Q2 | −0.1 | (−1.5 to 1.3) |  | −0.1 | (−1.4 to 1.3) |  | −1.2 | (−3.1 to 0.8) |  | −1.1 | (−3.0 to 0.9) |  | |
Q3 | −0.8 | (−2.1 to 0.6) |  | −0.8 | (−2.1 to 0.6) |  | −0.9 | (−2.9 to 1.1) |  | −0.7 | (−2.7 to 1.3) |  | |
Q4 | 0.3 | (−1.1 to 1.7) |  | 0.1 | (−1.3 to 1.5) |  | −0.8 | (−2.7 to 1.2) |  | −0.8 | (−2.8 to 1.1) |  | |
Q5 (highest) | −0.1 | (−1.5 to 1.2) | 0.94 | −0.6 | (−1.9 to 0.7) | 0.48 | −2.3 | (−4.2 to −0.4) | 0.05 | −2.3 | (−4.2 to −0.4) | 0.04 | |
Training practice | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | |
No | Baseline | Baseline | Baseline | Baseline | |||||||||
Yes | 0.9 | (0.1 to 1.8) | 0.03 | 0.6 | (−0.2 to 1.5) | 0.16 | −0.8 | (−2.0 to 0.5) | 0.23 | −0.9 | (−2.1 to 0.4) | 0.18 | |
GPs aged 50 and over | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | |
Some | Baseline | Baseline | Baseline | Baseline | |||||||||
None | 0.6 | (−1.0 to 2.1) | 0.46 | 0.3 | (−1.2 to 1.8) | 0.66 | −0.5 | (−2.7 to 1.8) | 0.70 | −0.5 | (−2.8 to 1.7) | 0.64 | |
All | 1.5 | (−0.4 to 3.3) | 0.13 | 0.8 | (−1.0 to 2.6) | 0.41 | −2.1 | (−4.5 to 0.4) | 0.10 | −2.5 | (−5.0 to −0.1) | 0.04 | |
GPs female | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | |
Some | Baseline | Baseline | Baseline | Baseline | |||||||||
None | −0.1 | (−1.7 to 1.6) | 0.95 | −0.7 | (−2.3 to 0.9) | 0.40 | −0.5 | (−2.7 to 1.7) | 0.68 | −1.0 | (−3.1 to 1.2) | 0.38 | |
All | 5.0 | (1.4 to 8.6) | 0.01 | 4.0 | (0.6 to 7.4) | 0.02 | −1.8 | (−6.3 to 2.6) | 0.42 | −2.1 | (−6.5 to 2.3) | 0.34 | |
GPs qualified in UK | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | |
Some | Baseline | Baseline | Baseline | Baseline | |||||||||
None | 1.5 | (−0.4 to 3.4) | 0.13 | 0.4 | (−1.4 to 2.2) | 0.68 | −2.2 | (−4.8 to 0.3) | 0.08 | −2.5 | (−5.0 to 0.0) | 0.05 | |
All | −0.4 | (−1.3 to 0.5) | 0.40 | −0.3 | (−1.1 to 0.6) | 0.55 | 0.9 | (−0.5 to 2.2) | 0.20 | 1.1 | (−0.2 to 2.4) | 0.09 | |
GP level deprivation | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | |
Q1 (least deprived) | Baseline | Baseline | Baseline | Baseline | |||||||||
Q2 | 0.4 | (−0.9 to 1.7) |  | 0.3 | (−1.0 to 1.5) |  | 1.9 | (0.1 to 3.7) |  | 1.0 | (−0.9 to 2.8) |  | |
Q3 | 0.1 | (−1.2 to 1.4) |  | −0.6 | (−1.9 to 0.7) |  | 3.2 | (1.3 to 5.0) |  | 2.1 | (0.2 to 4.0) |  | |
Q4 | 1.2 | (−0.2 to 2.5) |  | −0.2 | (−1.6 to 1.2) |  | 3.5 | (1.6 to 5.3) |  | 2.1 | (0.1 to 4.2) |  | |
Q5 (most deprived) | 4.4 | (2.9 to 5.9) | <0.001 | 2.5 | (0.8 to 4.2) | 0.14 | 3.5 | (1.5 to 5.6) | <0.001 | 1.8 | (−0.6 to 4.2) | 0.04 | |
GP rurality | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | |
Urban > 10 K | Baseline | Baseline | Baseline | Baseline | |||||||||
Town and fringe | −2.4 | (−3.5 to −1.4) | <0.001 | −1.5 | (−2.5 to −0.4) | 0.01 | −2.0 | (−3.7 to −0.4) | 0.01 | −1.6 | (−3.3 to 0.0) | 0.05 | |
Village, hamlet & isolated dwellings | −2.5 | (−4.7 to −0.4) | 0.02 | −1.6 | (−3.7 to 0.4) | 0.12 | −2.0 | (−5.1 to 1.0) | 0.19 | −1.2 | (−4.3 to 1.9) | 0.44 | |
GP general performance | Able to book appointment | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
90Â % and over | Baseline | Baseline | Baseline | Baseline | |||||||||
80-90 % | 1.0 | (0.1 to 1.9) |  | 0.6 | (−0.3 to 1.4) |  | 0.9 | (−0.4 to 2.2) |  | 0.8 | (−0.5 to 2.1) |  | |
<80 % | 3.1 | (1.5 to 4.7) | <0.001 | 1.7 | (0.1 to 3.3) | 0.04 | −1.3 | (−3.6 to 1.1) | 0.92 | −2.0 | (−4.3 to 0.4) | 0.70 | |
Able to see preferred GP | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | |
80Â % and over | Baseline | Baseline | Baseline | Baseline | |||||||||
60-80 % | 0.7 | (−0.3 to 1.7) |  | 0.4 | (−0.6 to 1.4) |  | 0.2 | (−1.2 to 1.7) |  | 0.2 | (−1.2 to 1.6) |  | |
<60 % | 1.7 | (0.5 to 2.9) | 0.01 | 1.0 | (−0.2 to 2.2) | 0.10 | −0.7 | (−2.5 to 1.0) | 0.47 | −0.9 | (−2.7 to 0.9) | 0.35 | |
Total QOF points | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | |
990 to 1000 (max) points | Baseline | Baseline | Baseline | Baseline | |||||||||
980 to 989 points | −0.2 | (−1.3 to 0.9) |  | −0.4 | (−1.4 to 0.7) |  | 1.4 | (−0.3 to 3.1) |  | 1.3 | (−0.4 to 2.9) |  | |
960 to 979 points | 1.2 | (0.0 to 2.4) |  | 0.9 | (−0.3 to 2.1) |  | 1.2 | (−0.5 to 2.8) |  | 1.1 | (−0.5 to 2.8) |  | |
<960 points | 1.4 | (0.0 to 2.7) | 0.02 | 0.9 | (−0.4 to 2.2) | 0.11 | 0.7 | (−1.3 to 2.6) | 0.23 | 0.4 | (−1.5 to 2.3) | 0.75 | |
GP specific cancer activities | Two week wait referral rate | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
Q1 (lowest) | Baseline | Baseline | Baseline | Baseline | |||||||||
Q2 | −1.8 | (−3.2 to −0.5) |  | −1.3 | (−2.6 to 0.1) |  | 0.1 | (−1.8 to 1.9) |  | 0.1 | (−1.8 to 2.0) |  | |
Q3 | −0.7 | (−2.1 to 0.7) |  | −0.1 | (−1.4 to 1.2) |  | 1.6 | (−0.3 to 3.6) |  | 1.8 | (−0.1 to 3.8) |  | |
Q4 | −2.9 | (−4.2 to −1.6) |  | −2.0 | (−3.3 to −0.7) |  | 1.4 | (−0.5 to 3.4) |  | 1.2 | (−0.7 to 3.2) |  | |
Q5 (highest) | −2.3 | (−3.6 to −0.9) | <0.001 | −1.5 | (−2.8 to −0.2) | 0.01 | 0.7 | (−1.2 to 2.7) | 0.20 | 0.7 | (−1.3 to 2.6) | 0.26 | |
Two week wait conversion | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | |
Q1 (lowest) | Baseline | Baseline | Baseline | Baseline | |||||||||
Q2 | −1.0 | (−2.4 to 0.3) |  | −0.7 | (−2.0 to 0.7) |  | 2.1 | (0.1 to 4.1) |  | 2.0 | (0.0 to 4.0) |  | |
Q3 | −1.7 | (−3.1 to −0.4) |  | −1.3 | (−2.6 to 0.0) |  | 1.1 | (−0.9 to 3.1) |  | 0.9 | (−1.1 to 2.9) |  | |
Q4 | −1.3 | (−2.6 to 0.0) |  | −1.0 | (−2.3 to 0.3) |  | 0.9 | (−1.1 to 2.9) |  | 0.7 | (−1.3 to 2.7) |  | |
Q5 (highest) | −1.0 | (−2.4 to 0.3) | 0.12 | −0.7 | (−2.0 to 0.6) | 0.23 | 1.6 | (−0.3 to 3.5) | 0.34 | 1.4 | (−0.5 to 3.3) | 0.46 | |
Two week wait detection | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | |
Q1 (lowest) | Baseline | Baseline | Baseline | Baseline | |||||||||
Q2 | −0.5 | (−1.9 to 0.8) |  | −0.2 | (−1.6 to 1.1) |  | 0.5 | (−1.4 to 2.4) |  | 0.5 | (−1.5 to 2.4) |  | |
Q3 | −1.6 | (−2.9 to −0.2) |  | −1.1 | (−2.4 to 0.2) |  | 1.9 | (0.0 to 3.8) |  | 1.9 | (0.0 to 3.8) |  | |
Q4 | −2.6 | (−4.1 to −1.2) |  | −1.9 | (−3.3 to −0.6) |  | 2.8 | (0.7 to 4.8) |  | 2.7 | (0.7 to 4.8) |  | |
Q5 (highest) | −2.0 | (−3.4 to −0.6) | <0.001 | −1.3 | (−2.6 to 0.0) | 0.01 | 0.3 | (−1.7 to 2.2) | 0.26 | 0.6 | (−1.3 to 2.5) | 0.15 | |
GP other activities | Average colonoscopy, sigmoidoscopy and upper GI endoscopy | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
T1 (lowest) | Baseline | Baseline | Baseline | Baseline | |||||||||
T2 | −0.8 | (−1.9 to 0.2) |  | −0.6 | (−1.6 to 0.4) |  | 2.3 | (0.8 to 3.8) |  | 2.4 | (0.9 to 3.9) |  | |
T3 (highest) | 0.5 | (−0.5 to 1.6) | 0.33 | 0.6 | (−0.4 to 1.6) | 0.28 | 2.5 | (1.0 to 4.0) | 0.001 | 2.4 | (0.9 to 3.9) | 0.002 | |
Emergency admissions | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | |
Q1 (lowest) | Baseline | Baseline | Baseline | Baseline | |||||||||
Q2 | −1.9 | (−3.2 to −0.5) |  | −1.6 | (−2.8 to −0.3) |  | 1.2 | (−0.7 to 3.2) |  | 1.5 | (−0.4 to 3.4) |  | |
Q3 | −0.3 | (−1.7 to 1.0) |  | −0.1 | (−1.5 to 1.2) |  | 1.7 | (−0.2 to 3.6) |  | 1.7 | (−0.2 to 3.6) |  | |
Q4 | −1.0 | (−2.3 to 0.3) |  | −0.8 | (−2.1 to 0.5) |  | 1.7 | (−0.3 to 3.6) |  | 1.4 | (−0.6 to 3.3) |  | |
Q5 (highest) | −2.0 | (−3.4 to −0.7) | 0.04 | −2.0 | (−3.3 to −0.8) | 0.03 | 2.1 | (0.1 to 4.0) | 0.04 | 1.6 | (−0.4 to 3.5) | 0.17 |